Potential physio-pathological effects of branched fatty acid esters of hydroxy fatty acids.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 20 10 2020
revised: 14 12 2020
accepted: 28 12 2020
pubmed: 8 1 2021
medline: 10 6 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Branched Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) are a new endogenous lipid class with recently uncovered interesting biological effects and which have been detected in food of plant and animal origins. Some FAHFAs can improve glucose tolerance and insulin sensitivity, stimulate insulin secretion, and exert anti-inflammatory effects. Other beneficial health effects have also been suggested, in particular against some cancers. FAHFAs could therefore be a potential therapeutic target for the treatment of numerous metabolic disorders such as type II diabetes, hepatic steatosis, cardiovascular diseases and various cancers. Their recent discovery has generated a great interest in the field of human health. This short review aims at bringing together the information available to date in the literature concerning their chemical synthesis, biosynthesis and degradation pathways as well as their potential physio-pathological beneficial effects.

Identifiants

pubmed: 33412159
pii: S0300-9084(20)30342-4
doi: 10.1016/j.biochi.2020.12.020
pii:
doi:

Substances chimiques

Fatty Acids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-22

Informations de copyright

Copyright © 2021 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Melha Benlebna (M)

DMEM, INRAE, Univ Montpellier, Montpellier, France.

Laurence Balas (L)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

Sylvie Gaillet (S)

DMEM, INRAE, Univ Montpellier, Montpellier, France.

Thierry Durand (T)

IBMM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

Charles Coudray (C)

DMEM, INRAE, Univ Montpellier, Montpellier, France.

François Casas (F)

DMEM, INRAE, Univ Montpellier, Montpellier, France.

Christine Feillet-Coudray (C)

DMEM, INRAE, Univ Montpellier, Montpellier, France. Electronic address: christine.coudray@inrae.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH